kabutan

TAKARA BIO INC.(4974) Summary

4974
TSE Prime
TAKARA BIO INC.
802
JPY
+14
(+1.78%)
Jan 29, 3:30 pm JST
5.24
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
0.94
Yield
ー%
Margin Trading Ratio
10.32
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
786 JPY 5.13 USD
Previous Close Jan 28
788 JPY 5.16 USD
High Jan 29, 3:09 pm
807 JPY 5.27 USD
Low Jan 29, 9:01 am
781 JPY 5.09 USD
Volume
226,500
Trading Value
0.18B JPY 1.18M USD
VWAP
794.46 JPY 5.19 USD
Minimum Trading Value
80,200 JPY 524 USD
Market Cap
0.10T JPY 0.64B USD
Number of Trades
524
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly High
1-Year Average
577
1-Year High Aug 21, 2025
6,306
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 178,400 643,200 3.61
Jan 16, 2026 157,700 626,900 3.98
Jan 9, 2026 149,500 655,000 4.38
Dec 26, 2025 144,200 709,800 4.92
Dec 19, 2025 206,400 748,600 3.63
Company Profile
TAKARA BIO INC. is a leading supplier of reagents and equipment for genetic research, with a strong focus on iPS cells and regenerative medicine. The company also offers contract services.
Sector
Chemicals
TAKARA BIO INC. operates businesses based on biotechnology, utilizing genetic engineering and cell engineering technologies. In its core reagents and equipment business, the company provides products and services for gene and cell analysis. In the contract business, TAKARA BIO INC. offers CDMO services including genetic analysis, testing, and regenerative medicine product-related contract services. In the gene therapy business, the company develops, manufactures, and sells manufacturing aids used in gene therapy drug production, and is advancing clinical development of gene therapy drugs using proprietary technologies.